borderline diabetics
Conditions
Interventions
Receive 8 g / day of Chlorella for 12 months.
Receive 8 g / day of Placebo (lactose) for 6 months. After 6 months, Receive 8g / day of Chlorella for 6 months.
Sponsors
Sun Chlorella Corp.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Adult Japanese males. 2. HbA1c (NGSP values) concentration; between 6.0% and 6.5% at the screening. 3. Written informed is required.
Exclusion criteria
Exclusion criteria: 1)BMI>30 2)Patient of the Diabetes or hypertension or hyperlipidemia. systolic blood pressure > 160 mmHg diastolic blood > 100 mmHg HbA1c > 7.4% LDL-Cholesterol > 190 mg/dL 3)These prescreened medicine. 4)These having Food for Specified Health Uses (FOSHU) and/or health food. 5)These having a history of serious diseases in metabolic and/or endocrine system. 6)Those that have extremely disheveled lifestyle and/or dietary habits. 7)Heavy alcohol drinker. 8)Those that are considered to be ineligible to participate to this test due to their abnormality at the screening test. 9)Diabetes or hypertension or hyperlipidemia patient who is NOT accompanied by obesity, but whose disease is attributed etiologically to hereditary factor or other non-obesity factors. 10)Those that are judged not applicable to this study by physicians. 11)The subject who takes warfarin. 12)Those participating in another trial or other investigational.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c,FFA, resistin gene expression and adipocytokine | — |
Countries
Japan
Outcome results
None listed